Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 16 | 2024 | 336 | 2.730 |
Why?
|
| Pneumococcal Infections | 14 | 2024 | 299 | 2.480 |
Why?
|
| Pneumococcal Vaccines | 15 | 2024 | 278 | 2.470 |
Why?
|
| Carrier State | 9 | 2023 | 92 | 1.380 |
Why?
|
| Nasopharynx | 9 | 2023 | 151 | 1.070 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 6 | 2024 | 42 | 0.950 |
Why?
|
| Child, Preschool | 17 | 2025 | 1748 | 0.720 |
Why?
|
| Vaccines, Conjugate | 8 | 2024 | 171 | 0.650 |
Why?
|
| Infant | 17 | 2025 | 2244 | 0.650 |
Why?
|
| Mothers | 2 | 2017 | 195 | 0.610 |
Why?
|
| HIV Seronegativity | 1 | 2017 | 52 | 0.570 |
Why?
|
| South Africa | 23 | 2025 | 7596 | 0.520 |
Why?
|
| HIV Seropositivity | 1 | 2017 | 265 | 0.480 |
Why?
|
| Child | 12 | 2025 | 2242 | 0.480 |
Why?
|
| Drug Resistance, Bacterial | 6 | 2025 | 135 | 0.480 |
Why?
|
| Specimen Handling | 3 | 2019 | 105 | 0.470 |
Why?
|
| Haemophilus influenzae | 1 | 2014 | 42 | 0.460 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 43 | 0.460 |
Why?
|
| Humans | 27 | 2025 | 14537 | 0.440 |
Why?
|
| Male | 19 | 2025 | 6754 | 0.440 |
Why?
|
| Vaccination | 5 | 2020 | 365 | 0.420 |
Why?
|
| Female | 19 | 2025 | 9103 | 0.420 |
Why?
|
| Adolescent | 10 | 2025 | 2985 | 0.400 |
Why?
|
| Prevalence | 9 | 2023 | 1192 | 0.390 |
Why?
|
| HIV Infections | 7 | 2024 | 5097 | 0.380 |
Why?
|
| Serogroup | 7 | 2024 | 150 | 0.360 |
Why?
|
| Adult | 10 | 2025 | 5913 | 0.350 |
Why?
|
| Young Adult | 7 | 2025 | 2498 | 0.300 |
Why?
|
| Genome, Bacterial | 4 | 2024 | 32 | 0.300 |
Why?
|
| Hospitalization | 5 | 2017 | 418 | 0.300 |
Why?
|
| Middle Aged | 8 | 2025 | 3601 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 293 | 0.270 |
Why?
|
| Pneumonia, Bacterial | 2 | 2016 | 54 | 0.250 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1422 | 0.250 |
Why?
|
| Corynebacterium diphtheriae | 1 | 2025 | 9 | 0.240 |
Why?
|
| Infant, Newborn | 6 | 2025 | 1479 | 0.240 |
Why?
|
| Serotyping | 4 | 2020 | 66 | 0.240 |
Why?
|
| Geographic Mapping | 1 | 2024 | 3 | 0.230 |
Why?
|
| Genetic Fitness | 1 | 2024 | 7 | 0.230 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 198 | 0.230 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2024 | 103 | 0.210 |
Why?
|
| Incidence | 4 | 2017 | 685 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 2 | 2020 | 181 | 0.200 |
Why?
|
| Metagenomics | 1 | 2022 | 13 | 0.200 |
Why?
|
| Rural Population | 3 | 2020 | 654 | 0.200 |
Why?
|
| Immunization Programs | 3 | 2020 | 81 | 0.200 |
Why?
|
| Genomics | 2 | 2019 | 109 | 0.190 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2024 | 196 | 0.180 |
Why?
|
| DNA Transposable Elements | 1 | 2020 | 4 | 0.180 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2020 | 35 | 0.170 |
Why?
|
| Virulence Factors | 1 | 2019 | 18 | 0.170 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2019 | 20 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2019 | 1160 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 176 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 260 | 0.150 |
Why?
|
| Circumcision, Male | 1 | 2018 | 99 | 0.140 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2016 | 10 | 0.140 |
Why?
|
| Pneumonia | 1 | 2017 | 131 | 0.130 |
Why?
|
| Rotavirus Infections | 1 | 2016 | 46 | 0.130 |
Why?
|
| Diarrhea | 1 | 2016 | 76 | 0.130 |
Why?
|
| Rotavirus Vaccines | 1 | 2016 | 53 | 0.120 |
Why?
|
| Aged | 4 | 2025 | 1740 | 0.120 |
Why?
|
| Bronchopneumonia | 1 | 2015 | 11 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2019 | 179 | 0.120 |
Why?
|
| Viruses | 1 | 2015 | 47 | 0.120 |
Why?
|
| Phylogeny | 3 | 2020 | 231 | 0.120 |
Why?
|
| Cause of Death | 3 | 2019 | 221 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2015 | 104 | 0.110 |
Why?
|
| Immunization Schedule | 1 | 2013 | 81 | 0.110 |
Why?
|
| Time Factors | 1 | 2014 | 507 | 0.100 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 60 | 0.080 |
Why?
|
| Perinatal Death | 2 | 2019 | 33 | 0.080 |
Why?
|
| Autopsy | 2 | 2019 | 140 | 0.080 |
Why?
|
| Stillbirth | 2 | 2019 | 83 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 119 | 0.080 |
Why?
|
| Age Factors | 2 | 2020 | 370 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2019 | 175 | 0.070 |
Why?
|
| Genotype | 2 | 2019 | 442 | 0.070 |
Why?
|
| Corynebacterium Infections | 1 | 2025 | 5 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2025 | 42 | 0.060 |
Why?
|
| Diphtheria | 1 | 2025 | 16 | 0.060 |
Why?
|
| Locomotion | 1 | 2024 | 3 | 0.060 |
Why?
|
| Penicillin Resistance | 1 | 2024 | 17 | 0.060 |
Why?
|
| Penicillins | 1 | 2024 | 25 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2016 | 480 | 0.060 |
Why?
|
| Risk Factors | 2 | 2020 | 1475 | 0.060 |
Why?
|
| Pregnancy | 2 | 2019 | 1862 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 468 | 0.050 |
Why?
|
| Immunization | 1 | 2022 | 63 | 0.050 |
Why?
|
| Poland | 1 | 2020 | 3 | 0.040 |
Why?
|
| Utah | 1 | 2020 | 3 | 0.040 |
Why?
|
| Phylogeography | 1 | 2020 | 15 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 22 | 0.040 |
Why?
|
| Tetracycline Resistance | 1 | 2020 | 4 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 48 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2020 | 19 | 0.040 |
Why?
|
| Diagnosis | 1 | 2019 | 7 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 13 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 13 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 44 | 0.040 |
Why?
|
| Gestational Age | 1 | 2019 | 80 | 0.040 |
Why?
|
| Proteins | 1 | 2019 | 20 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 24 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 11 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2019 | 97 | 0.040 |
Why?
|
| Genome, Human | 1 | 2019 | 25 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 56 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 21 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 23 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2018 | 8 | 0.040 |
Why?
|
| Analgesia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Pain Management | 1 | 2018 | 12 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2019 | 147 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 106 | 0.040 |
Why?
|
| Pain | 1 | 2018 | 41 | 0.040 |
Why?
|
| Global Health | 1 | 2019 | 193 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 198 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 21 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2017 | 64 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 30 | 0.040 |
Why?
|
| Age Distribution | 1 | 2017 | 107 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2017 | 81 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 306 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 28 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 154 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2015 | 54 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 149 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 529 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 254 | 0.030 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2015 | 100 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 799 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 411 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 329 | 0.030 |
Why?
|
| Coinfection | 1 | 2015 | 276 | 0.030 |
Why?
|